EVM14

BIOLOGICAL2 trials

Sponsors

Everest Medicines (Beijing) Co., Ltd.

Conditions

Selected Types of Solid TumorSquamous Non-Small Cell Lung Cancer sqNSCLC

Phase 1

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

RecruitingNCT07095868

Everest Medicines (Beijing) Co., Ltd.Selected Types of Solid Tumor

Start: 2025-11-17End: 2031-11-01Target: 94Updated: 2026-08-04

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients

Not yet recruitingNCT07614646

Everest Medicines (Beijing) Co., Ltd.Squamous Non-Small Cell Lung Cancer sqNSCLC

Start: 2026-11-01End: 2028-07-01Target: 13Updated: 2026-09-11